$1.330
-0.020 (-1.48%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de INM por análisis de gráficos similares
Alphio's INM stock price prediction model matches the current InMed Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.32 (-1.07%). The 1-week path is $1.31 (-1.68%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de InMed Pharmaceuticals Inc?
InMed Pharmaceuticals is not a good buy right now due to its low RSI of 31.092, indicating oversold conditions, and a significant 1-year change of -36.11%. While the recent merger news may provide some potential upside, the current financial performance shows a troubling trend with a net income loss of -2,966,336 USD in Q3 2026 and a gross margin drop to 15.97% in Q2 2026, which raises concerns about its profitability and sustainability.
INM cerró en $1.33 el Thursday, tras bajar -1.48%
InMed Pharmaceuticals Inc (INM) last closed at $1.33, losing -1.48%. These facts feed the 1-day and 1-week INM price prediction above.
Factores de la previsión
Los factores de la previsión de InMed Pharmaceuticals Inc (INM) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de INM, ordenadas por similitud.
Análisis de estacionalidad de INM
Historically the probability of a positive September return for INM is 6.82%. August offers the highest probability of a positive month at 40.62%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.